PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Intestinal Research10.5217/ir.2021.001242022202260-268One-year clinical efficacy and safety of indigo naturalis for active ulcerative colitis: a real-world prospective studyYuichi Matsuno, Takehiro Torisu, Junji Umeno, Hiroki Shibata, Atsushi Hirano, Yuta Fuyuno, Yasuharu Okamoto, Shin Fujioka, Keisuke Kawasaki, Tomohiko Moriyama, Tomohiro Nagasue, Keizo Zeze, Yoichiro Hirakawa, Shinichiro Kawatoko, Yutaka Koga, Yoshinao Oda, Motohiro Esaki, Takanari Kitazonohttp://irjournal.org/upload/pdf/ir-2021-00124.pdf, http://irjournal.org/journal/view.php?doi=10.5217/ir.2021.00124, http://irjournal.org/upload/pdf/ir-2021-00124.pdf
Journal of Crohn's and Colitis10.1093/ecco-jcc/jjz203.860202014Supplement_1S588-S588P732 The clinical efficacy and safety of indigo naturalis in induction & maintenance therapy for moderate-to-severe ulcerative colitis: A single-centre prospective uncontrolled open-label studyY Matsuno, A Hirano, T Torisu, Y Fuyuno, Y Okamoto, F Shin, M Tomohiko, J Umeno, Y Hirakawa, M Esaki, T Kitazonohttp://academic.oup.com/ecco-jcc/article-pdf/14/Supplement_1/S588/31851151/jjz203.860.pdf, http://academic.oup.com/ecco-jcc/article-pdf/14/Supplement_1/S588/31851151/jjz203.860.pdf
PLOS ONE10.1371/journal.pone.024133720201511e0241337Efficacy and safety of short-term therapy with indigo naturalis for ulcerative colitis: An investigator-initiated multicenter double-blind clinical trialKan Uchiyama, Shinichiro Takami, Hideo Suzuki, Kiyotaka Umeki, Satoshi Mochizuki, Nobushige Kakinoki, Junichi Iwamoto, Yoko Hoshino, Jun Omori, Shunji Fujimori, Akinori Yanaka, Yuji Mizokami, Toshifumi Ohkusahttps://dx.plos.org/10.1371/journal.pone.0241337
Journal of Digestive Diseases10.1111/1751-2980.126482018198468-474Clinical efficacy and safety of golimumab in biologically experienced and naive patients with active ulcerative colitis: A real-life experience from two Italian IBD centersBeatrice Orlandini, Gabriele Dragoni, Angela Variola, Arianna Massella, Siro Bagnoli, Riccardo Campi, Francesca Rogaihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2F1751-2980.12648, http://onlinelibrary.wiley.com/wol1/doi/10.1111/1751-2980.12648/fullpdf
Journal of Crohn's and Colitis10.1093/ecco-jcc/jjz203.790202014Supplement_1S545-S545P662 Efficacy and safety of tofacitinib in patients with moderate-to-severe ulcerative colitis: A real-world retrospective studyN Yoshimura, Soh Okano, Minako Sako, Masakazu Takazoehttp://academic.oup.com/ecco-jcc/article-pdf/14/Supplement_1/S545/31846125/jjz203.790.pdf, http://academic.oup.com/ecco-jcc/article-pdf/14/Supplement_1/S545/31846125/jjz203.790.pdf
Journal of the American College of Cardiology10.1016/j.jacc.2010.08.27920105613B59TCT-255: Consistent Efficacy and Safety of Everolimus-Eluting Stents In 5054 Patients From a Large Prospective Real World Study: One-Year Clinical Outcomes From the XIENCE V ® USA Studyhttps://api.elsevier.com/content/article/PII:S0735109710031311?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0735109710031311?httpAccept=text/plain
Gastroenterology10.1016/s0016-5085(18)31573-720181546S-380Sa1749 - Indigo Naturalis is Effective in Treatment-Refractory Patients with Ulcerative Colitis: Post-HOC Analysis from Indigo StudyMakoto Naganuma, Shinya Sugimoto, Keiichi Mitsuyama, Taku Kobayashi, Katsuyoshi Matsuoka, Tadakazu Hisamatsu, Kenji Watanabe, Takayuki Abe, Toshifumi Hibi, Yasuo Suzuki, Takanori Kanaihttps://api.elsevier.com/content/article/PII:S0016508518315737?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0016508518315737?httpAccept=text/plain
Yearbook of Gastroenterology10.1016/s0739-5930(08)70344-120062006143-144Efficacy of Rebamipide Enemas in Active Distal Ulcerative Colitis and Proctitis: A Prospective Study ReportG.R. Lichtensteinhttps://api.elsevier.com/content/article/PII:S0739593008703441?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0739593008703441?httpAccept=text/plain
Clinical and Experimental Gastroenterology10.2147/ceg.s356912014369Long-term efficacy and safety of once-daily mesalazine granules for the treatment of active ulcerative colitisStephan Böhm, Wolfgang Kruishttps://www.dovepress.com/getfile.php?fileID=21732
Journal of Crohn's and Colitis10.1093/ecco-jcc/jjac190.0679202317Supplement_1i677-i678P549 One-Year Comparison of Clinical and Endoscopic Outcomes of Tofacitinib Versus Vedolizumab for Ulcerative Colitis After Anti-Tumor Necrosis Factor Failure: A Real-World Cohort Study in the United StatesR Dalal, P Sharma, K Bains, J Pruce, J Allegrettihttps://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i677/48953856/jjac190.0679.pdf, https://academic.oup.com/ecco-jcc/article-pdf/17/Supplement_1/i677/48953856/jjac190.0679.pdf